Yasasever, V. Et Al. 1997. Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena. CLINICAL BIOCHEMISTRY , vol.30, no.1 , 53-56.

Yasasever, V., DINCER, M., CAMLICA, H., KARALOGLU, D., & DALAY, N., (1997). Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena. CLINICAL BIOCHEMISTRY , vol.30, no.1, 53-56.

Yasasever, Fatma Et Al. "Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena," CLINICAL BIOCHEMISTRY , vol.30, no.1, 53-56, 1997

Yasasever, Fatma V. Et Al. "Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena." CLINICAL BIOCHEMISTRY , vol.30, no.1, pp.53-56, 1997

Yasasever, V. Et Al. (1997) . "Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena." CLINICAL BIOCHEMISTRY , vol.30, no.1, pp.53-56.

@article{article, author={Fatma Vildan YASASEVER Et Al. }, title={Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on ''spiking'' phenomena}, journal={CLINICAL BIOCHEMISTRY}, year=1997, pages={53-56} }